Antifection

Shop By

Items 1001-1050 of 1186

Page
per page
Set Descending Direction
Catalog No.
Product Name
Application
Product Information
Citations
  1. HIV Integrase Inhibitor

    GSK1265744 (GSK744) is a potential inhibitor of HIV integrase with IC50 value of 3 nM
  2. HIV-1 attachment inhibitor

    BMS-626529 is a potent HIV-1 attachment inhibitor. BMS-663068 is also the phosphonooxymethyl prodrug of BMS-626529 that targets HIV-1 gp120 and prevents its binding to CD4(+) T cells.
  3. 1,3-beta-D-glucan synthesis inhibitor

    Micafungin Sodium is an inhibitor of 1, 3-beta-D-glucan synthesis.
  4. HIV protease inhibitor

    Nelfinavir Mesylate is a potent HIV protease inhibitor with Ki of 2 nM.
  5. aaRS inhibitor

    Aminoacyl tRNA synthetase-IN-1, is a bacterial aminoacyl tRNA synthetase (aaRS) inhibitor.
  6. HIV-1 maturation inhibitor

    GSK3532795, also known as BMS-955176, is a potent, orally active, second-generation HIV-1 maturation inhibitor. CAS: 1392312-45-6 (free base) 2023808-13-9 (HCl) 2023798-97-0 (HCl hydrate) 2097784-79-5 (oxalate)
  7. mold and yeast inhibitor

    Sorbic acid is a mold and yeast inhibitor. Used as a fungistatic agent for foods, especially cheeses.
  8. HIV-1 nucleotide reverse transcriptase inhibitor

    Tenofovir alafenamide fumarate (GS-7340 fumarate) is an investigational oral prodrug of Tenofovir. Tenofovir is a HIV-1 nucleotide reverse transcriptase inhibitor.
  9. HIV-1 nucleotide reverse transcriptase inhibitor

    Tenofovir alafenamide hemifumarate (GS-7340 hemifumarate) is an investigational oral prodrug of Tenofovir. Tenofovir is a HIV-1 nucleotide reverse transcriptase inhibitor.
  10. Fosfomycin calcium is a MurA and isopentenyl mevalonate kinase inhibitor that prevents synthesis of bacterial cell walls.
  11. Calcineurin/PP2B inhibitor

    Ascomycin is an ethyl analog of tacrolimus (FK506) with strong immunosuppressant properties. It has been researched for the treatment of autoimmune diseases and skin diseases, and to prevent rejection after an organ transplant.
  12. HIV fusion inhibitor

    Enfuvirtide Acetate (T-20) is a 36 amino acid peptide corresponding to a region of gp41, the transmembrane subunit of HIV-1 envelope protein.
  13. Antiviral fusion inhibitor

    Presatovir is a novel, orally bioavailable RSV fusion inhibitor, against a wide range of RSV A and B clinical isolates (mean EC50 = 0.43 nM).
  14. HIV maturation inhibitor

    GSK2838232-isomer is a novel human immune virus (HIV) maturation inhibitor being developed for the treatment of chronic HIV infection.

  15. HIV integrase inhibitor

    GSK744 is a potent HIV integrase inhibitor as an oral lead-in tablet and long-acting injectable for the treatment and prevention of HIV infection.
  16. HIV integrase inhibitor

    BI 224436 is a novel HIV-1 non-catalytic-site integrase inhibitor; has antiviral EC50s of <15 nM against different HIV-1 laboratory strains and cellular cytotoxicity of >90 μM.
  17. HIV integrase inhibitor

    Dolutegravir sodium is a HIV integrase inhibitor(IC50= 2.7 nM), modest activity against raltegravir-resistant signature mutants Y143R, Q148K, N155H, and G140S/Q148H.
  18. Thyroid inhibitor

    Aminothiazole can be used as a thyroid inhibitor and it has antibacterial activity.
  19. Flavin Mononucleotide (FMN) Inhibitor

    Ribocil B is the active S-isomer of ribocil which can inhibit flavin mononucleotide (FMN) with a KD of 6.6 nM.
  20. HIV replication inhibitor

    ABX-464, also known as SPL-464, is an inhibitor of the HIV replication potentially for the treatment of HIV infection.
  21. dipeptidase inhibitor

    Cilastatin is an inhibitor of dipeptidase (dehydropeptidase I), a renal dipeptidase.
  22. CYP51 inhibitor

    Tebuconazole is a triazole fungicide used agriculturally to treat plant pathogenic fungi.
  23. Protein synthesis inhibitor

    Blasticidin S is a nucleoside antibiotic isolated from Streptomyces griseochromogenes. Blasticidin S is a potent inhibitor of protein synthesis in both prokaryotic and eukaryotic cells.
  24. Topoisomerase inhibitor

    Zabofloxacin hydrochloride (DW-224a) is a novel fluoronaphthyridone quinolone that is considered a potent antibacterial candidate for clinical trials.
  25. efflux pump inhibitor

    PAβN dihydrochloride (MC-207110 dihydrochloride) is an efflux pump inhibitor.
  26. Candida albicans filamentation inhibitor

    Filastatin is a long-lasting inhibitor of Candida albicans filamentation. Filastatin inhibits adhesion by multiple pathogenic Candida species with an IC50 of ~3 μM in the GFP-based adhesion assay.
  27. neuraminidase inhibitor

    Neuraminidase-IN-1 is a neuraminidase inhibitor, with an IC50 of 0.21 μM. Neuraminidase-IN-1 has excellent activity against H1N1 influenza virus.
  28. rabies virus (RABV) entry inhibitor

    GRP-60367 is a first-in-class small-molecule rabies virus (RABV) entry inhibitor with nanomolar potency against some RABV strains.
  29. LpxC inhibitor

    ACHN-975 is a selective LpxC inhibitor, exhibiting a subnanomolar LpxC inhibitory activity and low MIC values (≤1 μg/mL) against a wide range of Gram-negative bacteria.

  30. HIV protease inhibitor

    DPC-681 is a potent and selective inhibitor of HIV protease with IC90s for wild-type HIV-1 of 4 to 40 nM.
  31. HIV protease inhibitor

    Darunavir is an HIV protease inhibitor
  32. UL97 kinase inhibitor

    Maribavir is an UL97 kinase inhibitor potentially for the treatment of cytomegalovirus (CMV) infection. The mechanism by which maribavir inhibits HCMV replication is by inhibition of an HCMV encoded protein kinase enzyme called UL97 or pUL97.
  33. HIV-1 capsid CTD dimerization inhibitor

    Ebselen (SPI-1005) is an inhibitor of HIV-1 capsid CTD dimerization. Ebselen can permeate the blood-brain barrier and inhibit inositol monophosphatase (IMPase). Ebselen is a non-toxic seleno-organic drug with anti-inflammatory and antioxidant properties. Ebselen inhibits QSOX1 enzymatic activity and has anticancer activity .
  34. CYP51 inhibitor

    Oteseconazole (VT-1161) is an orally active anti-fungal agent, potently binds to and inhibits Candida albicans CYP51 (Kd, <39 nM), shows no obvious effect on human CYP51.
  35. D77

    anti-HIV-1 inhibitor

    D77 is anti-HIV-1 inhibitor targeting the interaction between integrase and cellular LEDGF/p75.
  36. Fabl inhibitor

    AFN-1252(Debio 1452) is a potent inhibitor of enoyl-acyl carrier protein reductase (FabI), inhibited all clinical isolates of Staphylococcus aureus and Staphylococcus epidermidis at concentrations of ??0.12 μg/ml.
  37. diazabicyclooctane inhibitor

    Relebactam is a diazabicyclooctane inhibitor with activity against a wide spectrum of β-lactamases, including class A (extended-spectrum β-lactamases [ESBLs] and KPC) and class C (AmpC) enzymes.
  38. FabI enzyme inhibitor

    MUT056399 (Fab-001) is a highly potent inhibitor of the FabI enzyme of both S. aureus and E. coli with 50% inhibitory concentration IC50s of 12 nM and 58 nM, respectively.
  39. protein kinase G (PknG) inhibitor

    AX20017 is a small-molecule protein kinase G (PknG) inhibitor with an IC50 of 0.39 μM.
  40. CMV inhibitor

    Letermovir is a novel inhibitor of CMV, which targets the viral terminase complex and remains active against virus resistant to DNA polymerase inhibitors.
  41. DprE1 inhibitor

    BTZ043 is an inhibitor of decaprenyl-phosphoribose-epimerase (DprE1), with MICs of of 2.3 nM and 9.2 nM for M. tuberculosis H37Rv and Mycobacterium smegmatis, respectively.
  42. peptide deformylase inhibitor

    Lanopepden (GSK 1322322) is a peptide deformylase inhibitor active against Staphylococcus aureus strains with MICs of 1 and 1 mg/L for ATCC 29213 and ATCC 25923 strain, respectively.
  43. flaviviruse inhibitor

    NITD008 is a potent and selective flaviviruse inhibitor which can inhibit Dengue Virus Type 2 (DENV-2) with an EC50 of 0.64 μM.
  44. gyrase B inhibitor

    VXc-486 is a gyrase B inhibitor, with bactericidal activity.
  45. mycobactin biosynthesis inhibitor

    Salicyl-AMS is a mycobactin biosynthesis inhibitor which can also inhibit M. tuberculosis growth in vitro under iron-limited conditions.
  46. cyclophilin A inhibitor

    Cyclophilin inhibitor 1 is a potent and orally bioavailable cyclophilin A inhibitor, with a Kd of 5 nM, shows effective anti-HCV activity, with an EC50 of 98 nM for HCV 2a.
  47. LRS inhibitor

    Leu-AMS (compound 6), a leucine analogue, is a potent inhibitor of leucyl-tRNA synthetase (LRS) with an IC50 of 22.34 nM, which inhibits the catalytic activity of LRS but did not affect the leucine-induced mTORC1 activation.
  48. DENV NS2B-NS3 protease inhibitor

    ZINC03129319 is a dengue virus (DENV) NS2B-NS3 protease inhibitor extracted from patent US20150141521A1, has inhibition constants (Ki1) of 92±15 μM and Ki3 of 20±4 μM.
  49. AHCY inhibitor

    Aristeromycin, an adenosine analog, is an antibiotic and a potent S-adenosylhomocysteine hydrolase (AHCY) inhibitor.
  50. Mycobacterium tuberculosis

    AU1235 is an adamantyl urea inhibitor of Mycobacterium tuberculosis.

Items 1001-1050 of 1186

Page
per page
Set Descending Direction